Literature DB >> 18487372

Regulation of the receptor for TNFalpha, TNFR1, in human conjunctival epithelial cells.

Ellen B Cook1, James L Stahl, Frank M Graziano, Neal P Barney.   

Abstract

PURPOSE: Previous studies demonstrated that mast cell-derived TNFalpha stimulation is critical to the upregulation of intercellular adhesion molecule (ICAM)-1 on human conjunctival epithelial cells (HCECs), which is an important feature of ocular allergic inflammation. Shedding of TNFR1 by TNFalpha-converting enzyme (TACE) is a primary mechanism for the regulation of TNFalpha-mediated events. This process has not been examined in HCECs. In this study, the authors examined the regulation of TNFR1 expression and shedding by TACE on primary HCECs and the IOBA-NHC conjunctival epithelial cell line.
METHODS: Primary human conjunctival mast cells and epithelial cells were obtained from cadaveric conjunctival tissue. HCECs were incubated with and without activators (IgE-activated mast cell supernates, phorbol myristate acetate [PMA; to activate TACE], TNFalpha, and IFNgamma [to upregulate TNFR1]) for 24 hours. Pretreatment with the TACE inhibitor TAPI-2 was used to inhibit shedding of TNFR1. Supernates collected from the incubations were analyzed with ELISA for soluble TNFR1 (sTNFR1). With the use of flow cytometry, cells were harvested from these experiments for analysis of TNFR1 and ICAM-1 receptor expression.
RESULTS: IgE-activated conjunctival mast cell supernates upregulated the expression of TNFR1. TAPI-2 inhibited the PMA-induced release of sTNFR1 receptor and enhanced the surface expression of TNFR1 in HCECs in a dose-dependent manner. Upregulation of TNFR1 expression by priming with TAPI-2 and IFNgamma resulted in enhanced ICAM-1 expression in response to TNFalpha stimulation (significant change in the slope of the dose-response curve).
CONCLUSIONS: These results demonstrate that TACE promotes TNFR1 shedding in HCECs and that TNFR1 expression may be a more significant target than TNFalpha for intervention in ocular inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487372      PMCID: PMC2581452          DOI: 10.1167/iovs.08-1873

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  27 in total

1.  TNF-Induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase.

Authors:  P Dri; C Gasparini; R Menegazzi; R Cramer; L Albéri; G Presani; S Garbisa; P Patriarca
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

2.  Olopatadine inhibits TNFalpha release from human conjunctival mast cells.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Ann Allergy Asthma Immunol       Date:  2000-05       Impact factor: 6.347

3.  Amplifying factors in ocular surface diseases: apoptosis.

Authors:  Christophe Baudouin; Hong Liang
Journal:  Ocul Surf       Date:  2005-10       Impact factor: 5.033

4.  In vivo confocal microscopy and ex vivo flow cytometry: new tools for assessing ocular inflammation applied to rabbit lipopolysaccharide-induced conjunctivitis.

Authors:  Hong Liang; Christophe Baudouin; Antoine Labbé; Aude Pauly; Chantal Martin; Jean-Michel Warnet; Françoise Brignole-Baudouin
Journal:  Mol Vis       Date:  2006-11-16       Impact factor: 2.367

5.  Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1).

Authors:  Nina L Tsakadze; Srinivas D Sithu; Utpal Sen; William R English; Gillian Murphy; Stanley E D'Souza
Journal:  J Biol Chem       Date:  2005-12-06       Impact factor: 5.157

6.  Evidence for two distinct pathways in TNFalpha-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients.

Authors:  Q Shi; M Benderdour; P Lavigne; P Ranger; J C Fernandes
Journal:  Osteoarthritis Cartilage       Date:  2006-12-11       Impact factor: 6.576

7.  Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors.

Authors:  J Arribas; L Coodly; P Vollmer; T K Kishimoto; S Rose-John; J Massagué
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

8.  The role of conjunctival epithelial cells in chronic ocular allergic disease.

Authors:  M Hingorani; V L Calder; R J Buckley; S L Lightman
Journal:  Exp Eye Res       Date:  1998-11       Impact factor: 3.467

9.  Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type.

Authors:  Valérie Marin; Félix Montero-Julian; Sandra Grès; Pierre Bongrand; Catherine Farnarier; Gilles Kaplanski
Journal:  Eur J Immunol       Date:  2002-10       Impact factor: 5.532

10.  An essential role for ectodomain shedding in mammalian development.

Authors:  J J Peschon; J L Slack; P Reddy; K L Stocking; S W Sunnarborg; D C Lee; W E Russell; B J Castner; R S Johnson; J N Fitzner; R W Boyce; N Nelson; C J Kozlosky; M F Wolfson; C T Rauch; D P Cerretti; R J Paxton; C J March; R A Black
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

View more
  8 in total

1.  14-Deoxyandrographolide desensitizes hepatocytes to tumour necrosis factor-alpha-induced apoptosis through calcium-dependent tumour necrosis factor receptor superfamily member 1A release via the NO/cGMP pathway.

Authors:  D N Roy; S Mandal; G Sen; S Mukhopadhyay; T Biswas
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Shedding of the tumor necrosis factor (TNF) receptor from the surface of hepatocytes during sepsis limits inflammation through cGMP signaling.

Authors:  Meihong Deng; Patricia A Loughran; Liyong Zhang; Melanie J Scott; Timothy R Billiar
Journal:  Sci Signal       Date:  2015-01-27       Impact factor: 8.192

3.  Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages.

Authors:  Krasimira A Rozenova; Gergana M Deevska; Alexander A Karakashian; Mariana N Nikolova-Karakashian
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

4.  α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α.

Authors:  Angelia D Lockett; Samuel Kimani; Godfrey Ddungu; Sabine Wrenger; Rubin M Tuder; Sabina M Janciauskiene; Irina Petrache
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

5.  A pilot study on biomarkers for tendinopathy: lower levels of serum TNF-α and other cytokines in females but not males with Achilles tendinopathy.

Authors:  James E Gaida; Håkan Alfredson; Sture Forsgren; Jill L Cook
Journal:  BMC Sports Sci Med Rehabil       Date:  2016-02-25

6.  Inflammation-Driven Regulation of PD-L1 and PD-L2, and Their Cross-Interactions with Protective Soluble TNFα Receptors in Human Triple-Negative Breast Cancer.

Authors:  Tamir Baram; Nino Oren; Nofar Erlichman; Tsipi Meshel; Adit Ben-Baruch
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

7.  Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes.

Authors:  Shruti Sharma; Sharad Purohit; Ashok Sharma; Diane Hopkins; Leigh Steed; Bruce Bode; Stephen W Anderson; Ruth Caldwell; Jin-Xiong She
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

8.  Differential Effect of Proinflammatory Cytokines on Corneal and Conjunctival Epithelial Cell Mucins and Glycocalyx.

Authors:  Kiumars Shamloo; Priya Mistry; Ashley Barbarino; Christopher Ross; Vishal Jhanji; Ajay Sharma
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.